Prochlorperazine has 2 known drug interactions based on U.S. FDA drug labeling data. 1 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Deferoxamine Mesylate, Quizartinib. Patients taking Prochlorperazine should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 2
- Major
- 1
- Moderate
- 1
Major (1)
- Prochlorperazine + Deferoxamine Mesylate— Concurrent treatment may lead to temporary impairment of consciousness.
Moderate (1)
- Prochlorperazine + Quizartinib— QT interval prolonging drug. Coadministration with VANFLYTA may further increase incidence of QT prolongation. More freq…